Immuntherapie:Offener Zugang
Offener Zugang

Abstrakt

Influence of Natural Killer on Cancer

Abdul Rahman Asif

These individualised treatments involve reprogramming immune cells to kill cancer. Within the new study, funded by charity Blood wise, the analysis team created a genetically built version of a cell referred to as associate degree invariant natural killer T-cell CAR19-I NKT. Current CAR-T therapies area unit terribly high-priced (around £300,000 per patient) and have a tendency to be made-to-order for every patient. However, scientists behind the present study say their newer CAR-T medical aid has the potential to be ten-fold cheaper and might be factory made to alter one batch to be used on multiple patients.